State Key Laboratory of Molecular Oncology, Cancer Institute and Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
PLoS One. 2011;6(8):e23110. doi: 10.1371/journal.pone.0023110. Epub 2011 Aug 1.
Aurora-A is a serine/threonine protein kinase and plays an important role in the control of mitotic progression. Dysregulated expression of Aurora-A impairs centrosome separation and maturation, which lead to disrupted cell cycle progression and tumorigenesis. However, the molecular mechanism by which Aurora-A causes cell malignant transformation remains to be further defined. In this report, using transcription factors array and mRNA expression profiling array, we found that overexpression of Aurora-A suppressed transcription activity of AP-2α, a tumor suppressor that is often downregulated in variety of tumors, and inhibited expression of AP-2α-regulated downstream genes. These array-based observations were further confirmed by microwell colorimetric TF assay and luciferase reporter assay. Downregulated transcription activity of AP-2α by Aurora-A was found to be associated with reduced AP-2α protein stability, which appeared to be mediated by Aurora-A enhanced ubiquitin-dependent proteasomal degradation of AP-2α protein. Interestingly, Aurora-A-mediated AP-2α degradation was likely dependent Aurora-A kinase activity since inhibition of Aurora-A kinase activity was able to rescue Aurora-A-induced degradation of AP-2α. Moreover, we defined a physical interaction between Aurora-A and AP-2α, and such interaction might bridge the suppressive effect of Aurora-A on AP-2α protein stability. These findings provide new insights into molecular mechanism by which Aurora-A acts as an oncogenic molecule in tumor occurrence and malignant development.
极光激酶 A 是一种丝氨酸/苏氨酸蛋白激酶,在控制有丝分裂进程中发挥着重要作用。极光激酶 A 的表达失调会损害中心体的分离和成熟,从而导致细胞周期进程的中断和肿瘤的发生。然而,极光激酶 A 导致细胞恶性转化的分子机制仍有待进一步确定。在本报告中,我们通过转录因子阵列和 mRNA 表达谱阵列发现,极光激酶 A 的过表达抑制了肿瘤抑制因子 AP-2α的转录活性,AP-2α在多种肿瘤中经常下调,并且抑制了 AP-2α 调节的下游基因的表达。这些基于阵列的观察结果进一步通过微孔比色 TF 测定和荧光素酶报告基因测定得到证实。极光激酶 A 下调 AP-2α 的转录活性与 AP-2α 蛋白稳定性降低有关,这似乎是由极光激酶 A 增强的 AP-2α 蛋白泛素依赖性蛋白酶体降解介导的。有趣的是,极光激酶 A 介导的 AP-2α 降解可能依赖于极光激酶 A 的激酶活性,因为抑制极光激酶 A 的激酶活性能够挽救极光激酶 A 诱导的 AP-2α 降解。此外,我们定义了极光激酶 A 和 AP-2α 之间的物理相互作用,这种相互作用可能架起了极光激酶 A 对 AP-2α 蛋白稳定性的抑制作用。这些发现为极光激酶 A 在肿瘤发生和恶性发展中作为致癌分子的作用提供了分子机制的新见解。